TriaGen Wealth Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,001
Closed -$2.36M 193
2026
Q1
$2.36M Sell
8,001
-547
-6% -$162K 0.65% 37
2025
Q4
$2.33M Sell
8,548
-9
-0.1% -$2.45K 0.6% 38
2025
Q3
$2.31M Sell
8,557
-69
-0.8% -$18.8K 0.6% 49
2025
Q2
$2.38M Hold
8,626
0.72% 38
2025
Q1
$2.29M Buy
+8,626
New +$2.13M 0.81% 29
2022
Q2
Sell
-15,235
Closed -$3.62M 163
2022
Q1
$3.62M Buy
15,235
+6,515
+75% +$1.53M 1.88% 8
2021
Q4
$1.99M Hold
8,720
0.98% 31
2021
Q3
$1.69M Sell
8,720
-25
-0.3% -$5.07K 0.92% 34
2021
Q2
$1.85M Sell
8,745
-8,835
-50% -$1.87M 0.96% 31
2021
Q1
$3.59M Buy
+17,580
New +$3.46M 2.06% 5

Other funds holding CME

TriaGen Wealth Management's CME Position: Q2 2026 in Review

TriaGen Wealth Management sold out of CME Group (CME) in Q2 2026, closing a stake of 8,001 shares — an estimated $2.36M sold.

TriaGen Wealth Management first reported a position in CME in Q1 2021 and held it in 10 quarters. The position peaked at $3.62M in Q1 2022. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • TriaGen Wealth Management reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • TriaGen Wealth Management sold 8,001 CME Group shares in Q2 2026, an estimated $2.36M.
  • TriaGen Wealth Management first reported a position in CME Group in Q1 2021 and held it in 10 quarters.
  • TriaGen Wealth Management's CME Group position peaked at $3.62M in Q1 2022.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on TriaGen Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.